© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.
March 11th 2022
Drs Manesh Patel and Amr Abbas begin our discussion by laying out the defining characteristic of peripheral artery disease (PAD) and how it compares to coronary artery disease (CAD).
Drs Larry Allen and Chris Granger highlight the common risk factors associated with the development of PAD.
March 18th 2022
Our panel delves into the PAD diagnosis process, room for improvement, and socioeconomic factors.
A panel of experts share common challenges with the management of patients with PAD in health systems.
March 28th 2022
Four professionals discuss roles for diet, exercise, and medications in managing patients with PAD.
Four experts explain their treatment selection strategies, as well as therapy options, for patients with PAD.
April 1st 2022
The panel introduces data from the COMPASS trial, including patient population and efficacy and safety data.
8The panel shares how data from the VOYAGER PAD trial made an impact in the PAD treatment landscape.
April 8th 2022
Dr Amr Abbas discusses management of major adverse limb events in PAD.
The panel concludes with final thoughts on how to improve outcome for patients with PAD.
Family History of OSA Contributes to Pathogenesis of the Condition
Significant OSA Prevalence in Pediatric Patients with Pulmonary Hypertension
Severe Asthma Exacerbation Risk Reduced with Combined Albuterol-Budesonide